T cell memory to evolutionarily conserved and shared hemagglutinin epitopes of H1N1 viruses: A pilot scale study

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Duvvuri, Venkata R ^a   Duvvuri, Bhargavi ^a   Jamnik, Veronica ^a   Gubbay, Jonathan B ^b,c,d,e   Wu, Jianhong ^a   Wu, Gillian E ^a  

^a YORK UNIVERSITY   (Canada)

^b PUBLIC HEALTH ONTARIO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

CD4+ T cell epitope; Hemagglutinin; Immunodominant epitope; Influenza A H1N1 viruses; Novel conserved HA epitope

Indexed keywords

EPITOPE; GAMMA INTERFERON; HLA DRB1 ANTIGEN; INFLUENZA VIRUS HEMAGGLUTININ;

ADULT; AGED; ALLELE; ARTICLE; CD4+ T LYMPHOCYTE; CELL ASSAY; COMPUTER MODEL; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GENETIC CONSERVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLUENZA VIRUS A H1N1; MALE; MEMORY T LYMPHOCYTE; NONHUMAN; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PILOT STUDY; PREDICTION; SEASONAL INFLUENZA; VIRUS IMMUNITY; VIRUS STRAIN; VOLUNTEER;

ADULT; AGED; COMPUTATIONAL BIOLOGY; CROSS REACTIONS; ENZYME-LINKED IMMUNOSPOT ASSAY; EPITOPES; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS, H1N1 SUBTYPE; INTERFERON-GAMMA; MALE; MIDDLE AGED; PILOT PROJECTS; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84876982408     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-204     Document Type: Article

References (24)

1. Shinde V, Bridges CB, Uyeki TM. Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med 2009, 360:2616-2625.
2. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, Liu F. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009, 361:1945-1952.
3. Reed C, Angulo FJ, Swerdlow DL, Lipsitch M, Meltzer MI, Jernigan D, Finelli L. Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009. Emerg Infect Dis 2009, 15:2004-2007.
4. Tuite AR, Greer AL, Whelan M, Winter AL, Lee B, Yan P, Wu J. Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza. Can Med Assoc J 2010, 182:131-136.
5. Greenbaum JA, Kotturi MF, Kim Y, Oseroff C, Vaughan K, Salimi N, Vita R. Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci U S A 2009, 106:20365-20370.
6. Duvvuri VRSK, Moghadas SM, Guo H, Duvvuri B, Heffernan JM, Fisman DN, Wu GE, Wu J. Highly conserved cross-reactive CD4+ T-cell HA epitopes of seasonal and the 2009 pandemic influenza viruses. Influenza Other Respi Viruses 2010, 4:249-258.
7. Belz GT, Wodarz D, Diaz G, Nowak MA, Doherty PC. Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice. J Virol 2002, 76:12388-12393.
8. Zhou X, McElhaney JE. Age-related changes in memory and effector T cells responding to influenza A/H3N2 and pandemic A/H1N1 strains in humans. Vaccine 2011, 29:2169-2177.
9. Nielsen M, Lundegaard C, Blicher T, Peters B, Sette A, Justesen S, Buus S, Lund O. Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan. PLoS Comput Biol 2008, 4:e1000107.
10. Tan PT, Heiny AT, Miotto O, Salmon J, Ernesto TA, Marques ET, Lemonnier F, Thomas J. Conservation and diversity of Influenza A H1N1 HLA-restricted T cell epitope candidates for epitope-based vaccines. PLoS One 2010, 5:e8754.
11. Fonseca SG, Coutinho-Silva A, Fonseca LA, Segurado AC, Moraes SL, Rodrigues H, Hammer J. Identification of novel consensus CD4+ T-cell epitopes from clade B HIV-1 whole genome that are frequently recognized by HIV-1 infected patients. AIDS 2006, 20:2263-2273.
12. De Groot AS, Ardito M, McClaine EM, Moise L, Martin WD. Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine. Vaccine 2009, 27:5740-5747.
13. Karlsson RK, Jennes W, Page-Shafer K, Nixon DF, Shacklett BL. Poorly soluble peptides can mimic authentic ELISPOT responses. J Immunol Methods 2004, 285:89-92.
14. Ge X, Tan V, Bollyky PL, Standifer NE, James EA, Kwok WW. Assessment of seasonal influenza A virus-specific CD4+ T-cell responses to 2009 pandemic H1N1 swine-origin influenza A virus. J Virol 2010, 84:3312-3319.
15. Weinfurter JT, Brunner K, Capuano SV, Li C, Broman KW. Cross-reactive T cells Are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primates. PLoS Pathog 2011, 7(11):e1002381.
16. Axelsson-Robertson R, Weichold F, Sizemore D, Wulf M, Skeiky YA, Sadoff J, Maeurer MJ. Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8 T-cell responses. Immunology 2010, 129(4):496-505.
17. Gelder C, Davenport M, Barnardo M, Bourne T, Lamb J, Askonas B, Hill A, Welsh K. Six unrelated HLA-DR-matched adults recognize identical CD4+ T cell epitopes from influenza A haemagglutinin that are not simply peptides with high HLA-DR binding affinities. Int Immunol 1998, 10:211-222.
18. Kim J, Sette A, Rodda S, Southwood S, Sieling PA, Mehra V, Ohmen JD. Determinants of T cell reactivity to the mycobacterium leprae GroES homologue. J Immunol 1997, 159:335-343.
19. Phelps RG, Jones VL, Coughlan M, Turner AN, Rees AJ. Presentation of the good pasture autoantigen to CD4+ T cells is influenced more by processing constraints than by HLA class II peptide binding preferences. J Biol Chem 1998, 273:11440-11447.
20. Ma C, Whiteley PE, Cameron PM, Freed DC, Pressey A, Chen SL, Garni-Wagner B. Role of APC in the selection of immunodominant T cell epitopes. J Immunol 1999, 163:6413-6423.
21. Fairchild PJ, Wraith DC. Lowering the tone: Mechanisms of immunodominance among epitopes with low affinity for MHC. Immunol Today 1996, 17:80-85.
22. Rajnavolgyi E, Horvath A, Gogolak P, Toth GK, Fazekas G, Fridkin M, Pecht I. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites. Eur J Immunol 1997, 27:3105-3114.
23. Wilkinson TM, Li CK, Chui CS, Huang AK, Perkins M, Liebner JC, Lambkin-Williams R, Gilbert A, Oxford J, Nicholas B, Staples KJ, Dong T, Douek DC, McMichael AJ, Xu XN. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med 2012, 18(2):274-280.
24. Chicz RM, Urban RG, Lane WS, Gorga JC, Stern LJ, Vignali DA, Strominger JL. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 1992, 358(6389):764-768.